Pathogenesis and treatment of myasthenia gravis.
- 17 October 1981
- Vol. 283 (6298) , 1008-1012
- https://doi.org/10.1136/bmj.283.6298.1008
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Continuous subcutaneous neostigmine in the management of severe myasthenia gravis.BMJ, 1979
- Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate DegradationNew England Journal of Medicine, 1978
- Cancer and Teratogenesis: Infrequent Occurrence after Medical Use of Immunosuppressive Drugs*Australian and New Zealand Journal of Medicine, 1977
- An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravisClinical Immunology and Immunopathology, 1977
- Myasthenia GravisNew England Journal of Medicine, 1977
- Anti-Acetylcholine Receptor Antibody in Neonatal Myasthenia GravisNew England Journal of Medicine, 1977
- REMISSION OF MYASTHENIA GRAVIS FOLLOWING PLASMA-EXCHANGEThe Lancet, 1976
- THYMECTOMY IN MYASTHENIA GRAVIS: PATHOLOGIC, CLINICAL, AND ELECTROPHYSIOLOGIC CORRELATIONS*Annals of the New York Academy of Sciences, 1976
- The Effect of Thoracic Duct Lymph Drainage in Myasthenia gravisEuropean Neurology, 1973
- THE PATHOLOGY OF THE THYMUS IN MYASTHENIA GRAVISMedicine, 1949